Cargando…
Efficacy and safety of Morinda officinalis oligosaccharide capsules for depressive disorder: a systematic review and meta-analysis
OBJECTIVE: To evaluate the efficacy and safety of Morinda officinalis oligosaccharide (MOO) capsules for depressive disorder. METHODS: Eight electronic databases were searched for relevant studies from inception to April 19, 2020. Randomized controlled trials comparing MOO capsules with antidepressa...
Autores principales: | Du, Yun, Zheng, Qin, Ou, Zheng-Hang, Cao, Yu-Jia, Su, Xiao-Peng, Li, Chunbo, Qu, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Psiquiatria
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136385/ https://www.ncbi.nlm.nih.gov/pubmed/32997072 http://dx.doi.org/10.1590/1516-4446-2020-0945 |
Ejemplares similares
-
Effects of Oligosaccharides From Morinda officinalis on Gut Microbiota and Metabolome of APP/PS1 Transgenic Mice
por: Xin, Yang, et al.
Publicado: (2018) -
Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota
por: Zhang, Zheng-Wei, et al.
Publicado: (2022) -
Oligosaccharides from Morinda officinalis Slow the Progress of Aging Mice by Regulating the Key Microbiota-Metabolite Pairs
por: Xin, Yang, et al.
Publicado: (2019) -
Morinda officinalis oligosaccharides mitigate depression-like behaviors in hypertension rats by regulating Mfn2-mediated mitophagy
por: Yang, Lixuan, et al.
Publicado: (2023) -
Structural Characterization and Discrimination of Morinda officinalis and Processing Morinda officinalis Based on Metabolite Profiling Analysis
por: Kang, Liping, et al.
Publicado: (2022)